Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Connexin 43 | 11 | 2021 | 62 | 3.790 |
Why?
|
| Peptides | 7 | 2021 | 455 | 1.430 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2015 | 4 | 1.020 |
Why?
|
| Glutathione | 5 | 2014 | 343 | 0.920 |
Why?
|
| Cicatrix | 3 | 2021 | 60 | 0.890 |
Why?
|
| Neoplasms | 6 | 2014 | 1667 | 0.780 |
Why?
|
| Wound Healing | 4 | 2016 | 260 | 0.760 |
Why?
|
| Diabetic Foot | 2 | 2018 | 33 | 0.650 |
Why?
|
| Glioblastoma | 2 | 2019 | 219 | 0.650 |
Why?
|
| Peptidomimetics | 1 | 2018 | 7 | 0.630 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2018 | 29 | 0.610 |
Why?
|
| Molecular Targeted Therapy | 2 | 2018 | 170 | 0.570 |
Why?
|
| Skin | 2 | 2018 | 451 | 0.570 |
Why?
|
| Glioma | 1 | 2018 | 140 | 0.570 |
Why?
|
| Sulfhydryl Compounds | 3 | 2013 | 73 | 0.550 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 332 | 0.530 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 1536 | 0.520 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2014 | 282 | 0.510 |
Why?
|
| Peptide Fragments | 2 | 2018 | 483 | 0.500 |
Why?
|
| Tamoxifen | 1 | 2015 | 62 | 0.490 |
Why?
|
| Quinazolines | 1 | 2015 | 70 | 0.490 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 168 | 0.450 |
Why?
|
| Anti-Infective Agents | 1 | 2015 | 166 | 0.440 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 236 | 0.440 |
Why?
|
| Cysteine | 1 | 2013 | 112 | 0.440 |
Why?
|
| alpha 1-Antichymotrypsin | 1 | 2012 | 7 | 0.410 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2012 | 61 | 0.390 |
Why?
|
| Oxidation-Reduction | 5 | 2014 | 567 | 0.380 |
Why?
|
| Oxidative Stress | 3 | 2014 | 718 | 0.370 |
Why?
|
| Immune System | 1 | 2010 | 63 | 0.360 |
Why?
|
| Protective Agents | 1 | 2010 | 36 | 0.360 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2010 | 28 | 0.350 |
Why?
|
| Bone Marrow | 1 | 2010 | 168 | 0.350 |
Why?
|
| Hemoglobins | 1 | 2010 | 120 | 0.340 |
Why?
|
| Hypoxia | 1 | 2010 | 169 | 0.330 |
Why?
|
| Pulmonary Alveoli | 1 | 2009 | 62 | 0.320 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 508 | 0.310 |
Why?
|
| Up-Regulation | 1 | 2010 | 682 | 0.300 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 1070 | 0.290 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 940 | 0.270 |
Why?
|
| Epithelial Cells | 1 | 2009 | 431 | 0.270 |
Why?
|
| Animals | 12 | 2021 | 20881 | 0.270 |
Why?
|
| Reactive Oxygen Species | 4 | 2014 | 499 | 0.270 |
Why?
|
| Mammary Neoplasms, Experimental | 2 | 2016 | 114 | 0.250 |
Why?
|
| Humans | 18 | 2021 | 68618 | 0.230 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 214 | 0.230 |
Why?
|
| Tight Junctions | 2 | 2017 | 25 | 0.230 |
Why?
|
| Dermis | 1 | 2021 | 29 | 0.190 |
Why?
|
| Glutathione Transferase | 2 | 2013 | 166 | 0.190 |
Why?
|
| Signal Transduction | 4 | 2018 | 2689 | 0.190 |
Why?
|
| Serpins | 2 | 2013 | 205 | 0.190 |
Why?
|
| Keratinocytes | 1 | 2021 | 68 | 0.180 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2021 | 46 | 0.180 |
Why?
|
| Psoriasis | 1 | 2021 | 46 | 0.180 |
Why?
|
| Cell Hypoxia | 2 | 2010 | 92 | 0.180 |
Why?
|
| Prospective Studies | 3 | 2016 | 3705 | 0.170 |
Why?
|
| Biomimetic Materials | 1 | 2019 | 20 | 0.170 |
Why?
|
| Mice | 6 | 2017 | 8474 | 0.160 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2018 | 57 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1034 | 0.140 |
Why?
|
| Zonula Occludens-1 Protein | 1 | 2017 | 25 | 0.140 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 213 | 0.140 |
Why?
|
| Fibroblasts | 1 | 2021 | 902 | 0.140 |
Why?
|
| Female | 7 | 2021 | 38074 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2019 | 254 | 0.140 |
Why?
|
| Stress, Mechanical | 1 | 2016 | 208 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2010 | 1174 | 0.130 |
Why?
|
| RNA, Neoplasm | 1 | 2016 | 76 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 219 | 0.130 |
Why?
|
| Cell Line | 3 | 2021 | 1752 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 118 | 0.130 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2017 | 145 | 0.130 |
Why?
|
| Administration, Topical | 1 | 2015 | 111 | 0.130 |
Why?
|
| Patient Safety | 1 | 2016 | 202 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2016 | 237 | 0.120 |
Why?
|
| Nitric Oxide | 2 | 2014 | 382 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1851 | 0.120 |
Why?
|
| Leg Ulcer | 1 | 2014 | 26 | 0.120 |
Why?
|
| Gap Junctions | 1 | 2014 | 29 | 0.120 |
Why?
|
| Central Nervous System Diseases | 1 | 2014 | 40 | 0.110 |
Why?
|
| Glutaredoxins | 1 | 2013 | 12 | 0.110 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2014 | 53 | 0.110 |
Why?
|
| Peroxidases | 1 | 2013 | 28 | 0.110 |
Why?
|
| Nitrogen | 1 | 2013 | 57 | 0.110 |
Why?
|
| Skin Diseases | 1 | 2014 | 122 | 0.100 |
Why?
|
| Glutathione Disulfide | 1 | 2012 | 31 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 132 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 139 | 0.100 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 284 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2012 | 304 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 1851 | 0.090 |
Why?
|
| Cisplatin | 1 | 2012 | 192 | 0.090 |
Why?
|
| Erythroid Cells | 1 | 2010 | 5 | 0.090 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2010 | 11 | 0.090 |
Why?
|
| GATA1 Transcription Factor | 1 | 2010 | 19 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2010 | 108 | 0.090 |
Why?
|
| Heme | 1 | 2010 | 17 | 0.090 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2010 | 17 | 0.090 |
Why?
|
| Inflammation | 1 | 2016 | 1030 | 0.090 |
Why?
|
| Reactive Nitrogen Species | 1 | 2010 | 32 | 0.090 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 306 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 756 | 0.080 |
Why?
|
| Middle Aged | 3 | 2016 | 21147 | 0.080 |
Why?
|
| Microvilli | 1 | 2009 | 22 | 0.080 |
Why?
|
| Cell Death | 1 | 2010 | 329 | 0.080 |
Why?
|
| Air | 1 | 2009 | 22 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 306 | 0.080 |
Why?
|
| Polyurethanes | 1 | 2009 | 21 | 0.080 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2010 | 268 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 189 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.080 |
Why?
|
| Male | 4 | 2021 | 37321 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 1174 | 0.070 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 659 | 0.070 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 1173 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2015 | 7029 | 0.070 |
Why?
|
| Cytokines | 1 | 2010 | 866 | 0.070 |
Why?
|
| Young Adult | 1 | 2016 | 5717 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2021 | 124 | 0.050 |
Why?
|
| Ligands | 2 | 2014 | 317 | 0.050 |
Why?
|
| Adult | 2 | 2016 | 21403 | 0.050 |
Why?
|
| Aged | 1 | 2016 | 14862 | 0.050 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 120 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 493 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 2083 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 532 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| Peroxiredoxins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 322 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 5300 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2014 | 163 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 536 | 0.030 |
Why?
|
| Alleles | 1 | 2014 | 386 | 0.030 |
Why?
|
| Homeostasis | 1 | 2014 | 291 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2014 | 1330 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3259 | 0.020 |
Why?
|